HOOKIPA Pharma completes 1-for-10 reverse stock split, effective July 9, 2024

HOOKIPA Pharma Inc.

1-for-10 reverse split effective 5:00 p.m. ET on July 9, 2024; par value unchanged at $0.0001.
Authorized shares reduced from 400M to 40M; fractional shares cashed out.
Outstanding shares reduced from ~96.6M to ~9.7M immediately after split.
Conversion ratios/exercise prices adjusted for convertible preferred stock, stock options, and equity plans.
Reverse split was previously disclosed and affects all stockholders uniformly.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.